跳至主要内容
临床试验/EUCTR2013-002029-40-SE
EUCTR2013-002029-40-SE进行中(未招募)1 期

Aprepitant – effect and safety in treatment of atopic dermatitis

Karolinska Institutet0 个研究点目标入组 50 人开始时间: 2013年6月12日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Ongoing atopic dermatitis (diagnosted by dermatologist, Williams criteria).
  • - Moderate to severe disease (SCORAD > 20).
  • - Local treatment have not given sufficient effect.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 50
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Age over 40 or under 20 years
  • - Skin infection
  • - Other sytemic treatment for the atopic dermatitis
  • - Other diseases
  • - Other regular medicial treatment (contraceptives not included here)
  • - Dark skin (skin type VI)

研究者

相似试验

Aprepitant – effect and safety in treatment of... | 临床试验